WB
www.basetherapeutics.com
The startup develops a genetic engineering platform for natural killer cells and other cell therapy products aimed at treating lung cancer, liver cancer, glioma, and hematological tumors. Their technology enhances the safety and effectiveness of in vivo and in vitro gene editing applications for healthcare providers.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a genetic engineering platform for natural killer cells and other cell therapy products aimed at treating lung cancer, liver cancer, glioma, and hematological tumors. Their technology enhances the safety and effectiveness of in vivo and in vitro gene editing applications for healthcare providers.